Choose Category

Showing: 544 Reports

The global oncology precision medicine market, valued at USD 146 billion in 2025, is projected to reach USD 164 billion in 2026 and USD 382 billion by 2035, representing a CAGR of 9.87% during the forecast period 2026 to 2035. This growth is supported by the expanding use of biomarker-driven therapies, broader access to genomic profiling, increasing use of companion diagnostics and the development of targeted treatments for molecularly defined cancer populations. The growing global burden of can...

Checked Checkbox

Customization Available

Checked Checkbox

PDF, PPT, XLS

Price: $4,799 Onwards

The global automated aseptic sampling systems market, valued at USD 234 million in 2025, is projected to reach USD 254 million in 2026 and USD 564 million by 2035, with a CAGR of 9.3% during the forecast period 2026 to 2035. The market growth is supported by rising biologics and advanced-therapy manufacturing, stronger contamination-control expectations, wider adoption of single-use and closed bioprocessing technologies, and demand for more frequent process data. Automated sampling systems can r...

Checked Checkbox

Customization Available

Checked Checkbox

PDF, PPT, XLS

Price: $4,799 Onwards

The global rapid protein quantification process analyzer systems market, valued at USD 192 million in 2025, is projected to reach USD 227 million in 2026 and USD 885 million by 2035, representing a CAGR of 16.3% during the forecast period 2026 to 2035. The market growth is supported by increasing demand for rapid and more reproducible protein concentration and titer measurements, wider adoption of process analytical technology (PAT), and the shift toward process-integrated, automated analytical...

Checked Checkbox

Customization Available

Checked Checkbox

PDF, PPT, XLS

Price: $4,799 Onwards

The global bispecific antibodies market, valued at USD 16.5 billion in 2025, is projected to reach USD 20.6 billion in 2026 and USD 81.5 billion by 2035, representing a CAGR of 16.5% during the forecast period 2026 to 2035. Developers are also moving beyond traditional CD3-based T-cell engagement. In April 2026, Merck initiated a pivotal Phase 2b/3 program for MK-8748 (Tiespectus), an investigational bispecific that directly activates Tie2 while inhibiting VEGF in neovascular age-related macular...

Checked Checkbox

Customization Available

Checked Checkbox

PDF, PPT, XLS

Price: $4,799 Onwards

The global extractables and leachables testing market, valued at USD 908 million in 2025, is projected to reach USD 1,009 million in 2026 and USD 2,501 million by 2035, representing a CAGR of 10.6% during the forecast period 2026 to 2035. This growth is supported by the increasing regulatory emphasis on patient safety, product quality, expanding use of polymer-based materials and single-use systems in pharmaceutical manufacturing, and rising development of biologics, injectable products, combina...

Checked Checkbox

Customization Available

Checked Checkbox

PDF, PPT, XLS

Price: $4,799 Onwards

The cosmeceuticals market, valued at USD 69.8 billion in 2025, is projected to reach USD 75.5 billion in 2026 and USD 153.5 billion by 2035, representing a CAGR of 8.2% during the forecast period 2026 to 2035. The skin care segment dominates the market, driven by increasing consumer demand for advanced skincare formulations and products targeting specific dermatological concerns.The anti-aging segment accounts for the largest market share, primarily owing to the growing emphasis on preventive sk...

Checked Checkbox

Customization Available

Checked Checkbox

PDF, PPT, XLS

Price: $0 Onwards

The dental market, valued at USD 41.03 billion in 2025, is projected to reach USD 44.71 billion in 2026 and USD 133.68 billion by 2035, representing a CAGR of 12.94% during the forecast period 2026 to 2035. Technological advancement is also influencing the structure of the dental market. Digital dentistry solutions, including intraoral scanners, cone-beam computed tomography, computer-aided design and manufacturing, three-dimensional printing, practice-management software and artificial intellig...

Checked Checkbox

Customization Available

Checked Checkbox

PDF, PPT, XLS

Price: $4,799 Onwards

The allogeneic cell therapy market, valued at USD 383 million in 2025, is projected to reach USD 650 million in 2026 and USD 6,013 million by 2035, representing a CAGR of 28% during the forecast period 2026 to 2035. Growth is being supported by expanding clinical pipelines, the potential for off-the-shelf availability, scalable batch manufacturing from qualified donor-derived cells and cell banks, advances in cell engineering, and increasing investment in automated manufacturing and commercializ...

Checked Checkbox

Customization Available

Checked Checkbox

PDF, PPT, XLS

Price: $4,799 Onwards

The global cell therapy manufacturing market, valued at USD 4.8 billion in 2025, is estimated to reach USD 6.0 billion in 2026 and USD 12.5 billion by 2035, representing a CAGR of 8.53% during the forecast period 2026 to 2035. Growth is being supported by the expanding clinical pipeline, additional commercial launches, increasing manufacturing outsourcing, capacity investment and adoption of closed, automated and digitally connected production systems. According to American Society of Gene & Cel...

Checked Checkbox

Customization Available

Checked Checkbox

PDF, PPT, XLS

Price: $4,799 Onwards

The global biologics fill finish manufacturing market, valued at USD 5.1 billion in 2025, is projected to reach USD 5.4 billion in 2026 and USD 9.4 billion by 2035, representing a CAGR of 6.33% during the forecast period 2026 to 2035. This growth is supported by expanding pipelines of antibodies, recombinant proteins, vaccines, other advanced biologics, and continued investment in automated aseptic fill and finish technologies to enhance manufacturing efficiency and product quality. In June 2026...

Checked Checkbox

Customization Available

Checked Checkbox

PDF, PPT, XLS

Price: $4,799 Onwards

Checked Checkbox

Customization Available

Checked Checkbox

PDF, PPT, XLS

Price: $4,799 Onwards

The global digital biomanufacturing market, valued at $2.4 billion in 2025, is projected to reach $2.8 billion in 2026 and $12.0 billion by 2035, representing a CAGR of 17.6% during the forecast period 2026 to 2035. Based on type of biologic manufactured, antibodies account for the largest share, at 70%, while the cell and gene therapies segment is expected to grow fastest, at a CAGR of 29%. In-house developers currently capture 65% of the market by end user, while contract manufacturers are exp...

Checked Checkbox

Customization Available

Checked Checkbox

PDF, PPT, XLS

Price: $4,799 Onwards

The Europe antibody drug conjugates market, valued at USD 3.26 billion in 2025, is projected to reach USD 3.58 billion in 2026 and USD 4.98 billion by 2035, representing a CAGR of 3.7% during the forecast period 2026 to 2035. Antibody-drug conjugates (ADCs) combine the targeting specificity of a monoclonal antibody with potent cytotoxic payloads through specialized linkers, enabling selective delivery of anticancer agents to antigen-expressing tumor cells. For market sizing, the Europe scope in...

Checked Checkbox

Customization Available

Checked Checkbox

PDF, PPT, XLS

Price: $4,799 Onwards

The North America antibody drug conjugates market, valued at USD 10.35 billion in 2025, is projected to reach USD 12.33 billion in 2026 and USD 17.73 billion by 2035, representing a CAGR of 4.1% during the forecast period 2026 to 2035. Over the years, ADC applications have expanded beyond hematological cancers into breast, lung, ovarian, urothelial, cervical and other solid tumors, with development increasingly moving into earlier lines of treatment. More than 370 ADC candidates had entered clin...

Checked Checkbox

Customization Available

Checked Checkbox

PDF, PPT, XLS

Price: $4,799 Onwards

The global biostatistics and statistical programming services market, valued at USD 3.28 billion in 2025, is estimated at USD 3.52 billion in 2026 and is projected to reach USD 6.65 billion by 2035, representing a CAGR of 7.3% during the forecast period. Market growth is supported by rising statistical workload per clinical-development programs, flexible outsourcing of specialist biometrics capacity, and expanding regulatory and post-market statistical requirements. North America leads the globa...

Checked Checkbox

Customization Available

Checked Checkbox

PDF, PPT, XLS

Price: $4,799 Onwards

The global artificial organs and bionics market, valued at USD 29.40 billion in 2025, is estimated at USD 31.46 billion in 2026 and is projected to reach USD 54.13 billion by 2035, representing a CAGR of 6.21% during the forecast period 2026 to 2035. Growth is being supported by sustained demand for long-duration organ support and the wider use of automated, wearable and restorative systems across chronic and irreversible conditions. Specialty clinics & rehabilitation centers represent the large...

Checked Checkbox

Customization Available

Checked Checkbox

PDF, PPT, XLS

Price: $4,799 Onwards

The antibody drug conjugates market, valued at USD 15.47 billion in 2025, is projected to reach USD 18.57 billion in 2026 and USD 43.56 billion by 2035, representing a CAGR of 9.9% during the forecast period 2026 to 2035. Market growth is expected to be supported by the expanding global oncology therapeutics landscape, increasing commercialization of targeted cancer therapies, sustained industry investment, and the rising adoption of advanced treatment modalities across healthcare systems. Breas...

Checked Checkbox

Customization Available

Checked Checkbox

PDF, PPT, XLS

Price: $4,799 Onwards

The global bioinformatics market was valued at USD 17.3 billion in 2025 and is estimated at USD 19.8 billion in 2026. It is projected to reach USD 52.6 billion by 2035, representing an 11.5% CAGR from 2026 to 2035. Expanding multi-omics workloads, production-grade analytical workflows and clinical interpretation needs are increasing demand for specialized bioinformatics platforms and services. Generalized knowledge management tools dominate the knowledge management tools segment in 2026; special...

Checked Checkbox

Customization Available

Checked Checkbox

PDF, PPT, XLS

Price: $4,799 Onwards